1Goss PE, Reid C, Pintilie M. Male breast carcinoma:A review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996.Cancer,1999,85:629-639.
2Taylor CW,Green S,Dalton WS,et al.Multicenter randomised clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer. J Clin Oncol, 1998,16:993-999.
3Bonneterre J, Thurlimann B, Robertson J. Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the tamoxifen or Arimidex randomized group efficacy and tolerability study. J Clin Oncol,2000,18: 3748-3757.
1Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004 [ J ]. CA Cancer J Clin,2004,54( 1 ) :8-29.
2Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005 [ J ]. CA Cancer J Clin ,2005,55 ( 1 ) : 10-30
3Giordano SH, Cohen DS, Buzdar AU, et al. Breast carcinoma in men : a population-based study [ J ]. Cancer,2004,101 ( 1 ) :51-57.
4Agrawal A, Ayantunde AA, Rampaul R,et al. Male breast cancer: a review of clinical management[ J]. Breast Cancer Res Treat ,2007, 103(1) :11-21.
5Giordano SH, Perkins GH, Broglio K, et al. Adjuvant systemic therapy for male breast carcinoma [ J ]. Cancer, 2005, 104 ( 11 ) : 2359-2364.
6Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer[ J ]. Lancet,2006,367 (9510) :595-604.
7William GK. Treatment of advanced male breast cancer[ J]. Cancer,1981,47 (9) :2185.
8Lopez M, Barduagni A. Cyproterone acetate in advanced male breast cancer[ J]. Cancer, 1982,49( 1 ) :9 - 11.
9Pannuti F, Martoni A, Busutti L, et al. High-dose medroxyprogesterone acetate in advanced male breast cancer [ J ]. Cancer Treat Rep 1982,66(10):1763-1765.
10Muggia FM, Cassileth PA, Ochoa M, et al. Treatment of breast cancer with medroxyprogesterone acetate [ J ]. Ann Intern Med, 1968,68(2) :328-337.
